top of page

News & Events

Boston ONS supports oncology programs and is now offering event management packages to best suit your program needs. Check it out!

Tue, Feb 17
New Strategies for HER2-Positive Breast Cancer: Moving Current Therapies Into Earlier Settings
Zoom
RSVP
Feb 17, 2026, 6:30 PM – 7:30 PM
Zoom
Hosted by Med Learning Group Presented by Neil Lyengar, MD, Department of Hematology and Medical Oncology, Associate Professor, Emory University School of Medicine, Atlanta, GA
Mon, Mar 02
The HER2 Hurdle: Molecular Profiling and Emerging HER2 Targeted Therapies for Patients with NSCLC
Zoom
RSVP
Mar 02, 2026, 6:30 PM – 7:30 PM
Zoom
Presented by Dr. Dietrich Hosted by Med Learning Group
Thu, Jan 15
Enhancing Patient Care and Addressing Progression with Immune Checkpoint Inhibitors in Non-Melanoma Skin Cancers
Zoom
Details
Jan 15, 2026, 6:30 PM – 10:30 PM
Zoom
Program Chair - Nina Ran, MD, MS Mohs Micrographic Surgery and Dermatologic Oncology Fellow Brigham & Women's Hospital Dana-Farber Cancer Institute Boston, MA
Thu, Jan 15
Boston ONS Annual Meeting
Capital Grille
Details
Jan 15, 2026, 6:00 PM – 9:30 PM
Capital Grille, 900 Boylston St, Boston, MA 02115, USA
Join the Boston ONS Chapter for this year's annual meeting! We look forward to sharing the teams 2025 accomplishments and exciting plans for 2026!

Search

A Treatment for Patients with METex14 Skipping Metastatic NSCLC ~ 10/4/22 @ 6pm

A Treatment for Patients with METex14 Skipping Metastatic NSCLC ~ 10/4/22 @ 6pm

A Treatment for Patients with METex14 Skipping Metastatic NSCLC ~ 10/4/22 @ 6pm

INTERESTED!? Please contact Sarah Sievering directly via text or call to 617-549-4146. Feel free to email her as well.

Sep 28, 20221 min read

Pyruvate Kinase Deficiency: Clinical Manifestations and a New Treatment Option ~ Virtual - 10/12/22

Pyruvate Kinase Deficiency: Clinical Manifestations and a New Treatment Option ~ Virtual - 10/12/22

Pyruvate Kinase Deficiency: Clinical Manifestations and a New Treatment Option ~ Virtual - 10/12/22

Sep 20, 20220 min read

Educating Your Patients on IMBRUVICA Treatment for CLL/SLL A Case-Based Approach ~ Wednesday, 9/21

Educating Your Patients on IMBRUVICA Treatment for CLL/SLL A Case-Based Approach ~ Wednesday, 9/21

Educating Your Patients on IMBRUVICA Treatment for CLL/SLL A Case-Based Approach ~ Wednesday, 9/21

Sep 12, 20220 min read

BLENREP in Practice: A Patient Profile-Based Interactive Discussion ~ 10/25/22

PROGRAM DETAILS You are cordially invited to participate in a patient profile-based program focused on the use of BLENREP for appropriate...

Sep 12, 20221 min read

Fall Half Day Seminar & Vendor Fair ~ NOW OPEN for Member Registration! Don't miss this CNE event!

Fall Half Day Seminar & Vendor Fair ~ NOW OPEN for Member Registration! Don't miss this CNE event!

Fall Half Day Seminar & Vendor Fair ~ NOW OPEN for Member Registration! Don't miss this CNE event!

Fall Seminar NOW OPEN for Registration! Agenda Topics will include: · Oncology Care for the Bisexual Patient · ...

Aug 31, 20221 min read

Learn more about the Treatment of Carcinoid Syndrome Diarrhea ~ 9/14/22 @ 6:00pm

Learn more about the Treatment of Carcinoid Syndrome Diarrhea ~ 9/14/22 @ 6:00pm

Learn more about the Treatment of Carcinoid Syndrome Diarrhea ~ 9/14/22 @ 6:00pm

Click here to Register! Use code 500600.

Aug 16, 20221 min read

Learn more about Treatment of Carcinoid Syndrome Diarrhea ~ 9/13/22 @6:30pm

Learn more about Treatment of Carcinoid Syndrome Diarrhea ~ 9/13/22 @6:30pm

Learn more about Treatment of Carcinoid Syndrome Diarrhea ~ 9/13/22 @6:30pm

Click here to Register. Use code 500607.

Aug 16, 20221 min read

Please join us for a clinical overview of VORAXAZE ~ 9/7/22 @6:30pm

Please join us for a clinical overview of VORAXAZE ~ 9/7/22 @6:30pm

Please join us for a clinical overview of VORAXAZE ~ 9/7/22 @6:30pm

Click here to register!

Aug 16, 20221 min read

DLBCL and Epcoritamab, A CD3xCD20 Bispecific ~ 8/4/22 @ 6PM

Thursday August 4th @ 6:00 pm Atlantic Fish Co. 761 Boylston St, Boston, MA 02116 Presentation: DLBCL Overview Epcoritamab MOA (DuoBody®...

Jul 27, 20221 min read

Tisotumab Vedotin: Adverse Events and Management ~ 8/2/22 @6pm

Join us Tuesday August 2nd @ 6:00 pm Abe & Louie's 793 Boylston St, Boston, MA 02116 Presentation: - Tisotumab Vedotin MOA - FDA...

Jul 27, 20221 min read

Changing the Standard of Care for Patients with RET+ mNSCLC or Advanced Thyroid Cancer ~ 9/29/22

Changing the Standard of Care for Patients with RET+ mNSCLC or Advanced Thyroid Cancer ~ 9/29/22

Changing the Standard of Care for Patients with RET+ mNSCLC or Advanced Thyroid Cancer ~ 9/29/22

Hear from an expert during this presentation, which will cover the following topics:  Identification and management of certain RET+...

Jun 14, 20222 min read

TONIGHT @ Morton's @6pm! Don't miss it!

TONIGHT @ Morton's @6pm! Don't miss it!

TONIGHT @ Morton's @6pm! Don't miss it!

Jun 1, 20220 min read

TABALISSE First and Only SYK Inhibitor for Immune Thrombocytopenia ~ 6/9/22 @ 6:30pm

TABALISSE First and Only SYK Inhibitor for Immune Thrombocytopenia ~ 6/9/22 @ 6:30pm

TABALISSE First and Only SYK Inhibitor for Immune Thrombocytopenia ~ 6/9/22 @ 6:30pm

Click here to register today!

May 23, 20221 min read

Pyruvate Kinase Deficiency: A Underrecognized Cause of Chronic Hemolytic Anemia ~ Tuesday, 5/24/22

Pyruvate Kinase Deficiency: A Underrecognized Cause of Chronic Hemolytic Anemia ~ Tuesday, 5/24/22

Pyruvate Kinase Deficiency: A Underrecognized Cause of Chronic Hemolytic Anemia ~ Tuesday, 5/24/22

Don't miss this! Save your seat today! Share posting here or flyer below!

May 16, 20221 min read

Lymphoma Clinical Update: Hodgkin Lymphoma ~ 5/5/22 @ Grill 23

Lymphoma Clinical Update: Hodgkin Lymphoma ~ 5/5/22 @ Grill 23

Lymphoma Clinical Update: Hodgkin Lymphoma ~ 5/5/22 @ Grill 23

Interested? Email Carrie directly at cmaricic@seagen.com

Apr 28, 20221 min read

DLBCL: Unmet Needs in an Evolving Treatment Landscape ~ 5/18/22 @ Abe & Louie's

DLBCL: Unmet Needs in an Evolving Treatment Landscape ~ 5/18/22 @ Abe & Louie's

DLBCL: Unmet Needs in an Evolving Treatment Landscape ~ 5/18/22 @ Abe & Louie's

Interested? Email Todd directly at todd.boudreau@adctherapeutics.com.

Apr 28, 20221 min read

Cytopenic Myelofibrosis (MF) and VONJO (Pacritinib) Overview ~ 5/25/22

Cytopenic Myelofibrosis (MF) and VONJO (Pacritinib) Overview ~ 5/25/22

Cytopenic Myelofibrosis (MF) and VONJO (Pacritinib) Overview ~ 5/25/22

Apr 28, 20220 min read

TAVALISSE First and Only SYK Inhibitor for Immune Thrombocytopenia (ITP) ~ 6/9/22 @ Morton's

TAVALISSE First and Only SYK Inhibitor for Immune Thrombocytopenia (ITP) ~ 6/9/22 @ Morton's

TAVALISSE First and Only SYK Inhibitor for Immune Thrombocytopenia (ITP) ~ 6/9/22 @ Morton's

Apr 27, 20220 min read

Pyruvate Kinase Deficiency: Clinical Manifestations and a New Treatment Option ~ 5/9/22 @12:00 EST

Pyruvate Kinase Deficiency: Clinical Manifestations and a New Treatment Option ~ 5/9/22 @12:00 EST

Pyruvate Kinase Deficiency: Clinical Manifestations and a New Treatment Option ~ 5/9/22 @12:00 EST

Click to learn more and register

Apr 27, 20221 min read

Improving Biomarker Driven Precision Therapy in NSCLC: Uncovering ALK in Clinical Practice

May 10th, 2022 5:00-6:00pm ET Link to Register The overall goal of this project is to help identify critical gaps in standard biomarker...

Apr 27, 20222 min read

bottom of page